Sfoglia per Autore
Artificial Intelligence and liver: Opportunities and barriers
2023 Balsano, C; Burra, P; Duvoux, C; Alisi, A; Piscaglia, F; Gerussi, A; Brunetto, M; Bonino, F; Montalti, R; Campanile, S; Persico, M; Alvaro, D; Santini, S; Invernizzi, P; Carbone, M; Masarone, M; Eccher, A; Siciliano, B; Vento, M; Ficuciello, F; Cabitza, F; Penasa, S; Donatelli, P
Autoimmune liver diseases
2023 Scaravaglio, M; Carbone, M; Invernizzi, P
Corrigendum to: “An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs” [J Hepatol 75 (2021) 572-581, (S0168827821003342), (10.1016/j.jhep.2021.04.055)]
2023 Cordell, H; Fryett, J; Ueno, K; Darlay, R; Aiba, Y; Hitomi, Y; Kawashima, M; Nishida, N; Khor, S; Gervais, O; Kawai, Y; Nagasaki, M; Tokunaga, K; Tang, R; Shi, Y; Li, Z; Juran, B; Atkinson, E; Gerussi, A; Carbone, M; Asselta, R; Cheung, A; de Andrade, M; Baras, A; Horowitz, J; Ferreira, M; Sun, D; Jones, D; Flack, S; Spicer, A; Mulcahy, V; Byan, J; Han, Y; Sandford, R; Lazaridis, K; Amos, C; Hirschfield, G; Seldin, M; Invernizzi, P; Siminovitch, K; Ma, X; Nakamura, M; Mells, G
Open challenges in the management of autoimmune hepatitis
2023 Gerussi, A; Halliday, N; Carbone, M; Invernizzi, P; Thorburn, D
Endocrinology and Metabolic Diseases (Including Diabetes)
2023 Cristoferi, L; Ciardullo, S; Invernizzi, P; Perseghin, G; Carbone, M
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival
2023 Murilloperez, C; Ioannou, S; Hassanally, I; Trivedi, P; Corpechot, C; van der Meer, A; Lammers, W; Battezzati, P; Lindor, K; Nevens, F; Kowdley, K; Bruns, T; Cazzagon, N; Floreani, A; Mason, A; Gulamhusein, A; Ponsioen, C; Carbone, M; Lleo, A; Mayo, M; Dalekos, G; Gatselis, N; Thorburn, D; Verhelst, X; Pares, A; Londono, M; Janssen, H; Invernizzi, P; Vuppalanchi, R; Hirschfield, G; Hansen, B; Levy, C
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe
2023 Murillo Perez, C; Gerussi, A; Trivedi, P; Corpechot, C; Van Der Meer, A; Maria Battezzati, P; Lindor, K; Nevens, F; Kowdley, K; Bruns, T; Cazzagon, N; Floreani, A; Tanaka, A; Ma, X; Mason, A; Gulamhusein, A; Ponsioen, C; Carbone, M; Lleo, A; Mayo, M; Dalekos, G; Gatselis, N; Thorburn, D; Verhelst, X; Pares, A; Janssen, H; Hirschfield, G; Hansen, B; Invernizzi, P; Lammers, W
The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis
2023 Christine Halma, J; Cristoferi, L; Carbone, M
Risk stratification in primary sclerosing cholangitis
2023 Mulinacci, G; Cristoferi, L; Palermo, A; Lucà, M; Gerussi, A; Invernizzi, P; Carbone, M
Exploring the landscape of steatotic liver disease in the general US population
2023 Ciardullo, S; Carbone, M; Invernizzi, P; Perseghin, G
Noninvasive identification of probable fibrotic nonalcoholic steatohepatitis across the spectrum of glucose tolerance in the United States
2023 Ciardullo, S; Carbone, M; Invernizzi, P; Perseghin, G
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis
2023 Cristoferi, L; Porta, M; Bernasconi, D; Leonardi, F; Gerussi, A; Mulinacci, G; Palermo, A; Gallo, C; Scaravaglio, M; Stucchi, E; Maino, C; Ippolito, D; D'Amato, D; Ferreira, C; Nardi, A; Banerjee, R; Valsecchi, M; Antolini, L; Corso, R; Sironi, S; Fagiuoli, S; Invernizzi, P; Carbone, M
Authors' reply to Zou et al
2023 Ciardullo, S; Carbone, M; Invernizzi, P; Perseghin, G
Setanaxib, a first-in-class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo-controlled, phase 2 trial
2023 Invernizzi, P; Carbone, M; Jones, D; Levy, C; Little, N; Wiesel, P; Nevens, F
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis
2022 Cristoferi, L; Porta, M; Bernasconi, D; Leonardi, F; Gerussi, A; Mulinacci, G; Palermo, A; Gallo, C; Scaravaglio, M; Stucchi, E; Maino, C; Ippolito, D; D'Amato, D; Ferreira, C; Nardi, A; Banerjee, R; Valsecchi, M; Antolini, L; Corso, R; Sironi, S; Fagiuoli, S; Invernizzi, P; Carbone, M
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence?
2022 Lacetera, R; Roggero, L; Vercelloni, P; Uzzo, M; Carbone, M; Invernizzi, P; L'Imperio, V; Pieruzzi, F; Sinico, R
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid
2022 De Vincentis, A; D'Amato, D; Cristoferi, L; Gerussi, A; Malinverno, F; Lleo, A; Colapietro, F; Marra, F; Galli, A; Fiorini, C; Coco, B; Brunetto, M; Niro, G; Cotugno, R; Saitta, C; Cozzolongo, R; Losito, F; Giannini, E; Labanca, S; Marzioni, M; Marconi, G; Morgando, A; Pellicano, R; Vanni, E; Cazzagon, N; Floreani, A; Chessa, L; Morelli, O; Muratori, L; Pellicelli, A; Pompili, M; Ponziani, F; Tortora, A; Rosina, F; Russello, M; Cannavo, M; Simone, L; Storato, S; Vigano, M; Abenavoli, L; D'Anto, M; De Gasperi, E; Distefano, M; Scifo, G; Zolfino, T; Calvaruso, V; Cuccorese, G; Palitti, V; Sacco, R; Bertino, G; Frazzetto, E; Alvaro, D; Mulinacci, G; Palermo, A; Scaravaglio, M; Terracciani, F; Galati, G; Ronca, V; Zuin, M; Claar, E; Izzi, A; Picardi, A; Invernizzi, P; Vespasiani-Gentilucci, U; Carbone, M; Feletti, V; Mussetto, A; Venere, R; Bernaccioni, G; Graciella Pigozzi, M; Fagiuoli, S; Terreni, N; Pozzoni, P; Baiocchi, L; Grassi, G; Vinci, M; Bellia, V; Boldizzoni, R; Casella, S; Omazzi, B; Poggi, G
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls
2022 Murillo Perez, C; Fisher, H; Hiu, S; Kareithi, D; Adekunle, F; Mayne, T; Malecha, E; Ness, E; van der Meer, A; Lammers, W; Trivedi, P; Battezzati, P; Nevens, F; Kowdley, K; Bruns, T; Cazzagon, N; Floreani, A; Mason, A; Pares, A; Londono, M; Invernizzi, P; Carbone, M; Lleo, A; Mayo, M; Dalekos, G; Gatselis, N; Thorburn, D; Verhelst, X; Gulamhusein, A; Janssen, H; Smith, R; Flack, S; Mulcahy, V; Trauner, M; Bowlus, C; Lindor, K; Corpechot, C; Jones, D; Mells, G; Hirschfield, G; Wason, J; Hansen, B; Sturgess, R; Healey, C; Gunasekera, A; Kallis, Y; Wright, G; Mathialahan, T; Evans, R; Gasem, J; Ramanaden, D; Ward, E; Bhalme, M; Southern, P; Maggs, J; Yousif, M; Srivastava, B; Foxton, M; Collins, C; Prasad, Y; Porras-Perez, F; Yapp, T; Patel, M; Ede, R; Carte, M; Koss, K; Sattianayagam, P; Grimley, C; Tidbury, J; Mansour, D; Beckley, M; Hollywood, C; Ramag, J; Gordon, H; Ridpath, J; Grover, B; Abouda, G; Rees, I; Narain, M; Salam, I; Banim, P; Das, D; Matthews, H; Mohammed, F; Jones, R; Sen, S; Bird, G; Prince, M; Prasad, G; Kitchen, P; Hutchinson, J; Gupta, P; Shah, A; Saha, S; Pollock, K; Barclay, S; Mcdonald, N; Rushbrook, S; Przemioslo, R; Millar, A; Mitchell, S; Davis, A; Naqvi, A; Lee, T; Ryder, S; Collier, J; Cramp, M; Aspinal, R; Booth, J; Williams, E; Hussaini, H; Christie, J; Chaudhry, T; Mann, S; Ala, A; Maltby, J; Corbett, C; Singhal, S; Hoeroldt, B; Butterworth, J; Douglas, A; Sinha, R; Panter, S; Shearman, J; Bray, G; Roberts, M; Forton, D; Taylor, N; Jafar, W; Cowan, M; Ch'Ng, C; Rahman, M; Wesley, E; Jain, S; Mandal, A; Wright, M; Trivedi, P; Gordon, F; Unitt, E; Austin, A; Palegwala, A; Vemala, V; Higham, A; Fraser, J; Li, A; Ramakrishnan, S; King, A; Whalley, S; Gee, I; Keld, R; Fellows, H; Gotto, J; Millson, C
An update on novel pharmacological agents for primary sclerosing cholangitis
2022 Gallo, C; Howardson, B; Cristoferi, L; Carbone, M; Gershwin, M; Invernizzi, P
Hepatitis C virus infection and diabetes: a complex bidirectional relationship
2022 Ciardullo, S; Mantovani, A; Ciaccio, A; Carbone, M; Invernizzi, P; Perseghin, G
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile